nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Angiotensin, fibrinolysis, and vascular homeostasis
|
Vaughan, Douglas E |
|
2001 |
87 |
8S1 |
p. 18-24 7 p. |
artikel |
2 |
Angiotensin II and atherosclerosis
|
Weiss, Daiana |
|
2001 |
87 |
8S1 |
p. 25-32 8 p. |
artikel |
3 |
Angiotensin II and the pathophysiology of cardiovascular remodeling
|
Williams, Bryan |
|
2001 |
87 |
8S1 |
p. 10-17 8 p. |
artikel |
4 |
Clinical studies of CS-866, the newest angiotensin II receptor antagonist
|
Neutel, Joel M |
|
2001 |
87 |
8S1 |
p. 37-43 7 p. |
artikel |
5 |
Concluding comment
|
Weber, Michael A. |
|
2001 |
87 |
8S1 |
p. 44- 1 p. |
artikel |
6 |
Experimental and clinical evidence that angiotensin II is an independent risk factor for cardiovascular disease
|
Brunner, Hans R |
|
2001 |
87 |
8S1 |
p. 3-9 7 p. |
artikel |
7 |
Introduction
|
Arakawa, Kikuo |
|
2001 |
87 |
8S1 |
p. 1-2 2 p. |
artikel |
8 |
New pharmacologic aspects of CS-866, the newest angiotensin II receptor antagonist
|
Koike, Hiroyuki |
|
2001 |
87 |
8S1 |
p. 33-36 4 p. |
artikel |